No headlines found.
No press releases found.
No news found.
Advanced Health Intelligence Ltd (AHI) is engaged in developing and delivering user-friendly biometric scans to render vital signs and health risk estimates to a smartphone. By leveraging the smartphone with purpose-built computer vision, machine learning models, and patented algorithms, AHI provides a private and secure way for individuals to perform biometric health-risk assessment and stratification. AHI's technology delivers simple-to-use, scalable, and cost-effective means to enable individuals to check, track and act towards better health outcomes. The combination of the patented and proprietary BodyScan dimensioning and composition capabilities and, FaceScan to return vital signs enables a unique health assessment capability made accessible anytime, anywhere through the smartphone.
Advanced Health Intelligence Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol AHI.
As of March 28, 2024, AHI stock price was flat at $1.50 with million shares trading.
AHI has a market cap of $42.01 million. This is considered a Sub-Micro Cap stock.
AHI has underperformed the market in the last year with a price return of +4.2% while the SPY ETF gained +33.6%. AHI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.9% and 0.0%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
AHI support price is $1.50 and resistance is $1.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AHI stock will trade within this expected range on the day.